After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

Daraxonrasib, an experimental pill for pancreatic cancer, has shown 'unprecedented' results and is taken as three pills once a day. The Food and Drug Administration has fast-tracked its approval process.